All News

What role will immunotherapy play in the future treatment of GI cancers? CURE spoke to Brian Hemphill, M.D., to find out.

When your cancer is just like the common cold.

How does one heal after a cancer diagnosis?

All members of the FDA’s Oncologic Drugs Advisory Committee (ODAC) voted to approve Rituxan for the treatment of some blood cancers.

Mohammad Jahanzeb, M.D., discusses the SystHERs study, which is looking closely at current treatment methods for HER2- positive metastatic breast cancer (MBC).

After publishing them in October 2016,the National Comprehensive Cancer Network (NCCN) is already seeking to update and expand their guidelines for diagnosing and treating patients with myeloproliferative neoplasms (MPNs).

Choosing a prosthesis requires a little work on the part of the wearer. Understanding options is not only helpful, but necessary.

What about hope? Don’t kill hope. Breast cancer and melanoma survivor shares what helped at the time of diagnosis and early on in her cancer treatment.

Adam M. Brufsky, M.D., Ph.D., discusses bone-targeted agents in breast cancer, and what we can expect for the future of this kind of therapy.

A recent study investigated racial and ethnic disparities in guideline-based care for cervical cancer.

It’s your choice to explain how your cancer battle has affected you, but it’s their choice to try and understand.

On learning to accept the ups and down of the journey despite how you feel

The FDA has approved Zejula (niraparib) for treatment of patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer in the maintence setting.

Kula for Karma, a nonprofit organization, offers yoga programs designed to aid patients with cancer as well as medical professionals, first responders and others, manage stress and improve quality of life.

In an interview with CURE, lead study author Scott Tagawa, M.D., discussed the latest findings with sacituzumab govitecan in patients with metastatic urothelial cancer.

Michael F. Press, M.D., Ph.D., shed light on the role of the receptor in breast cancer in a presentation during the 2017 Miami Breast Cancer Conference.

As the treatment landscape of head and neck cancer has changed significantly over the past year, immunotherapy has emerged as a key player in patient care.

Finding a balance amid the chaos of cancer.

How do you educate people about a cancer so rare that just one percent of the cancer population has it?

Patrick I. Borgen, M.D., discusses new discoveries that could lead to better, more individualized treatment for men with breast cancer.

An ongoing trial studying Keytruda (pembrolizumab) with the first-in-class IDO1 inhibitor epacadostat (INCB024360) can mean drastic change for patients with melanoma.

The American Health Care Act (AHCA), which President Donald Trump planned on replacing the Affordable Care Act (ACA) with, was pulled on Friday. The ACA is still the law of the land.

Breast implants, especially those with textured surfaces, may be associated with a rare type of lymphoma, according to a recent statement by the Food and Drug Administration (FDA).

Jim Kochenderfer, M.D., lends insight to the future of CAR T-cell therapy for hematologic malignancies.

Here are some tips for managing intimacy and self-care, during or after a cancer diagnosis.

It has always been clear to me that there is a cure for cancer. It is called money.

Bavencio (avelumab), a PD-L1-inhibitor, gained approval by the Food and Drug Administration (FDA) for some patients with Merkel cell carcinoma.

Sara Hurvitz, M.D. talks about recent and upcoming advancements in the treatment of HER2-positive breast cancer